Title: Tobacco Industry Expropriates Intellectual Property Rules
1Tobacco Industry Expropriates Intellectual
Property Rules
- Ellen R. Shaffer, PhD MPH
- Joseph Brenner, MA
- Sohil Sud, MD MA
- CPATH
- Center for Policy Analysis on Trade and Health
- Trans Pacific Partnership
- Jan. 31, 2012
2CPATH Mission
- Research, analysis and advocacy
- to advance global economic policies
- that improve and protect public health
-
-
2
3CPATH On Tobacco and Trade
- Shaffer, ER, JE Brenner and TPHouston.
International trade agreements a threat to
tobacco control policy. Tobacco Control
20051419-25. - Shaffer, ER, H Waitzkin, J Brenner, R
Jasso-Aguilar. Global Trade and Public Health.
American Journal of Public Health. January, 2005
4Tobacco Industry Expropriates IP
- Tobacco is a deadly product
- Countries are enacting increasingly strong and
effective tobacco control policies that are
proven to reduce tobacco use. - Industry has long contested these measures as
violations of trade agreement rules. - To reduce worldwide tobacco consumption, tobacco
must be carved out from all protections afforded
under the TPP. - AAFP, AAP, ACPM, ASAM, CPATH to Congress, 12/11
5Tobacco Is A Deadly Product
- Tobacco Consumption fast becoming the leading
preventable cause of illness and mortality - Annual death toll worldwide 5.2 million
- U.S. tobacco use still kills more than 400,000
people each year - Use of Tobacco Products
- Chile - 29 of population
- Singapore 15 of population, up from 12.6
- Vietnam 18 of population, down from 25
6Teen Smoking U.S.
- About 30 of youth smokers will continue smoking
and die early from a smoking-related disease. - People who start smoking before the age of 21
have the hardest time quitting. - Teen smokers are more likely to use alcohol and
illegal drugs - -Centers for Disease Control Prevention
7(No Transcript)
8(No Transcript)
9(No Transcript)
10Framework Convention on Tobacco Control
- to protect present and future generations from
the devastating health, social, environmental and
economic consequences of tobacco consumption and
exposure to tobacco smoke
- Established minimum standards in the areas of
- tobacco demand reduction
- passive smoking
- packaging and labeling
- health awareness
- advertising
- sale to minors
- smuggling
11Countries Are Enacting Protections
- Industry on the Run
- Countries limiting advertising on packaging
- Graphic warning labels Uruguay, US
- Plain packaging Australia
- Ban on point-of-sale displays Norway, Ireland
12 13Tobacco/Trade ThreatsLong History
- Tobacco added as a covered commodity in trade
round 1986-94 - Thailand forced to open market, 1990
- Canada dissuaded from plain packaging, 1994
14Tobacco Control in Uruguay
- 2009 Uruguayan Tobacco Control Measures
- Increase health messaging on the bottom portion
of cigarette packages from 50 to 80, - Mandate the placement of one of six selected
health images on packages. - Prohibit the use of brand families in which the
same brand name is used across various across
product lines (e.g., Malboro Red, Malboro Green,
Malboro Gold, etc).
15Lawsuit Philip Morris v Uruguay
Background In June 2009, Uruguayan government passed legislation to place larger pictorial warnings on cigarette packages and prohibit the use of brand families.
Basis of lawsuit Infringement on intellectual property without compensation
Trade Agreement 1991 Uruguay-Switzerland Bilateral Investment Treaty
Court of Arbitration International Centre for the Settlement of Investment Disputes (ICSID)
Status Currently undergoing procedural matters (e.g., jurisdiction)
16Australia
17Lawsuit Philip Morris v Australia
Background November 2011 legislation mandating uniform cigarette packaging, with brand names listed at the bottom, and with color, pictorial warnings covering the rest of the carton.
Basis of lawsuit Infringement on intellectual property without compensation
Trade Agreement 1993 Australia-Hong Kong Bilateral Investment Treaty
Court of Arbitration United Nations Commission on International Trade Law
Status Currently debating the merits and jurisdiction of the lawsuit
18Opposition from Big Tobacco
19Lawsuit Philip Morris v Norway
Background In January 2010, Norway instituted a ban on the point-of-sale display of tobacco products in retail outlets.
Basis of lawsuit Restriction of free movement of traded goods
Trade Agreement 1994 Agreement of the European Economic Area
Court of Arbitration Oslo District Court
Status Litigation ongoing advisory ruling submitted from the European Free Trade Association (EFTA) court
20Lawsuit Philip Morris v Ireland
Background In January 2010, Ireland instituted a ban on the point-of-sale display of tobacco products in retail outlets.
Basis of lawsuit Restriction of free movement of traded goods
Trade Agreement Violation of Irish constitutional law and EU law
Court of Arbitration High Court of Dublin
Status Ban still in effect litigation is ongoing
21Opposition from Big Tobacco
- How can a corporation file suit against a
country? - At stake the ability of sovereign states to
safeguard the health of their own citizens.
22Trade Agreements
- Bilateral
- Multilateral (e.g., NAFTA)
- International (e.g., TRIPS)
Company A
Philip Morris
Investor-State Espousal
Expropriation
23Weak Cases Delay Implementation
- Trademarks protect companies from use of their
brand by competitors - They do not confer unlimited rights to advertise
lethal products - Trademark rights under TRIPS are rights to
exclude third parties from using a trademark or
mark that is sufficiently similar as to cause
confusion concerning the source of the product. A
WTO panel has confirmed that these are negative
rights to exclude third parties and not positive
rights of use (EC Geographical Indications).
Hence, the purpose of the right is to protect the
ability of the rights holder to identify the
provenance of the product, and not to promote the
product per se. Benn McGrady, Georgetown Law
24Problems Ahead Trademark
- TPPA can expand rather than limit trademark and
other rights - Can extend trademark protections in foreign
markets
25Problems Ahead Expanding Corporate Rights to
Arbitrate TRIPS
- PMI claim Uruguay violates fair equitable
treatment and WTO/TRIPS obligations - Under the BITs umbrella clause
- Uruguay must observe the commitments it has
entered into with respect to the investments of
Swiss investors. - Commitments include obligations under TRIPS
26Expanding Corporate Rights
- Most Favored Nation (MFN) and other clauses are
designed to incorporate obligations from outside
of the agreement, including from BITs. These
include - Minimum standard of treatment (fair and equitable
treatment) Ensure compliance with customary
international law (CIL) - International law clauses Ensure treatment in
accordance with international law not limited
to CIL. - Umbrella clauses Observe any obligation with
regard to investments. - More favorable treatment clauses If another
agreement between the parties provides more
favorable treatment of investments, it will
prevail. - Most-favored nation treatment Ensure the most
favorable treatment provided to investors from
any third country. - Analysis by Forum on
Democracy
27Avoiding expansive investment clauses
- The US, Australia and New Zealand are using some
or all these approaches - Avoiding umbrella clauses
- Avoiding more favorable treatment clauses
- Limiting minimum treatment to CIL (not broader
international law)
28These reforms are not enough
- Limiting minimum treatment to CIL does not
restrain expropriation or expansive umbrella or
more favorable treatment clauses. - MFN treatment could incorporate expansive clauses
from older BITs. - 2 important limits on MFN in recent US FTAs do
not affect - Excluding arbitration and procedural treatment.
- Excluding differential treatment based on
reciprocal trade concessions. - - Forum on Democracy
29Effective Remedies IP
- Carve out tobacco trade and other industries
that pose extraordinary threats to public health,
food security, the environment, and public order
30Remedy 1. Tobacco Control
- Tariff and Nontariff Provisions Exclude tobacco
products from all trade rules and in each
relevant Schedule and Annex, including but not
limited to Market Access, Most Favored Nation,
National Treatment, Services, Intellectual
Property, and tariff reduction schedules.
31Remedy 2. Tobacco Control
- Notwithstanding any language to the contrary,
nothing in this agreement shall block, impede,
restrict, or modify the ability of any party to
take or maintain any action, relating to
manufactured tobacco products that is intended or
expected, according to the party, to prevent or
reduce tobacco use or its harms and costs or that
is reasonably likely to prevent or reduce tobacco
use or its harms, including tariffs and
restrictions on the marketing of tobacco or
tobacco products.
32Remedy 3. Tobacco Control
- Add Provisions of the Framework Convention on
Tobacco Control shall govern, in the event of any
conflict with this Agreement
33Challenges To Excluding Tobacco
- Corporate opposition
- We havent done it so far so it cant be done.
34Mounting Action, Take Tobacco Out San Francisco
- Trans-Pacific Partnership
35Reps. Lewis, Ways and Means Members For Public
Health in TPP
36Major medical and public health associations in
U.S. and worldwide support tobacco carve
outhttp//www.cpath.org/id47.html
37Remedies Dispute Rules (Investor-State)
- Exclude investor-state remedies as in the
Australia-US FTA. - Limit MFN treatment without it, TPPA carve-outs
and other reforms can be undermined by investor
recourse to more favorable provisions of older
FTAs and investment agreements.
38Public Health Objectives for Global Trade
- To assure democratic participation by public
health and transparency in trade policy - To develop mutually beneficial trade
relationships that create sustainable economic
development - To recognize the legitimate exercise of national,
regional and local government sovereignty to
protect population health
TPP
38
CPATH
39Public Health Objectives for Global Trade
- To exclude tariff and nontariff provisions in
trade agreements that address vital human
services - To exclude tobacco and tobacco products
- To exclude alcohol products
- To eliminate intellectual property provisions
related to pharmaceuticals from bilateral and
regional negotiations and promote trade
provisions which enable countries to exercise all
flexibilities provided by the Doha Declaration on
Public Health
TPP
39
CPATH
40CPATH on CAFTA and Access to Medicines in
Guatemala
- Shaffer, ER and JE Brenner. A trade
agreements impact on access to generic drugs.
Health Affairs, Web Exclusive. Aug. 25, 2009.
w957-w967.
41(No Transcript)
42Trade Advisory Committees 2005 Business 42
Public Health 0
Pharma 20 Public Health 0
Tobacco 7 Public Health 0
Alcohol 6 Public Health 0
Food 5 Public Health 0
Health Insurance 4 Public Health 0
TPP
42
43CPATH
- Center for Policy Analysis on Trade and Health
- Joseph Brenner
- Ellen R. Shaffer
- www.cpath.org
- ershaffer_at_cpath.org
- Phone 415-922-6204
- Fax 415-885-4091
TPP
43